Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
U.S. Reps to Gilead: Did your donation of free HIV prevention drug Truvada have strings attached?

In May, Gilead pledged to donate 2.4 million bottles of its HIV drug Truvada to the U.S. government’s effort to eradicate the disease, partly by preventing new infections. But now Gilead is facing accusations that its largesse may have suspicious underpinnings. The House Oversight Committee’s chairman, Rep. Elijah E. Cummings (D-MD), and three colleagues sent a letter to Gilead demanding details about what led to the company’s generous offer.

Published
01 July 2019
From
FiercePharma
Free, fast track access to PrEP now available in London

Those who meet the eligibility criteria will soon get a free, six month supply of PrEP. The improved access to PrEP comes thanks to HIV and sexual health charity, Terrence Higgins Trust (THT) and the UK’s busiest sexual health clinic, 56 Dean Street.

Published
01 July 2019
From
Gay Star News
England: More than a quarter of sexual health clinics closed to new PrEP trial places

Despite a promised expansion of 13,000 places, Seema Kennedy has revealed that 38 of the 147 sites taking part in the PrEP Impact Trial are closed to some new recruits to the trial.

Published
01 July 2019
From
Pharmaceutical Journal
Is the “PrEP4Love” Campaign Reaching African Americans?

The Chicago-based HIV-prevention effort garnered about 41 million views in its first four months alone. And that’s not all.

Published
26 June 2019
From
Poz
US: Federal Guidelines May Inadvertently Restrict Women’s Access to Effective HIV Protection

Restrictive recommendations for pre-exposure prophylaxis (or PrEP) issued by the Centers for Disease Control and Prevention (CDC) systematically disqualified nearly all women at risk for HIV and/or motivated to use the medication, researchers at the Yale School of Public Health and George Washington University have found.

Published
25 June 2019
From
Yale School of Public Health
Desperate patients turn to buyers clubs

What do you do when the NHS won’t buy the treatment you need?

Published
25 June 2019
From
The Economist (free registration required)
US: Senate Bill Proposes Expansion of PrEP Access

A bill introduced by Senator Kamala Harris (D-CA) Thursday, the PrEP Access and Coverage Act, would expand access to pre-exposure prophylaxis (PrEP), medications that can reduce the risk of HIV infection by up to 92%.

Published
25 June 2019
From
Pharmacy Times
The Slow Rollout Of PrEP Is Denying Gay Men Their Right To Human Dignity

Gay men are already a socially marginalised and stigmatised group – their health can no longer continue to be sacrificed, National AIDS Trust's Yused Azad writes

Published
24 June 2019
From
Huffington Post
CytoDyn Signs Groundbreaking Memorandum of Understanding with Thai Red Cross AIDS Research Centre to Study Pre-Exposure Prophylaxis Use of Leronlimab (PRO 140) in People at High Risk of Acquiring HIV

“The rationale for the use of leronlimab as PrEP is grounded in the long-standing observation that individuals deficient for the CCR5 co-receptor are nearly completely resistant to sexual transmission of HIV,” said Dr. Jonah Sacha, Associate Professor of the Oregon Health & Science University. Dr. Sacha continued, “Given the difficulties many patients face with adherence to daily oral antiretroviral therapy drugs as PrEP, once-weekly leronlimab as PrEP could be transformative in slowing the epidemic.”

Published
20 June 2019
From
CytoDyn press release
USPSTF Recommendation for PrEP: Reflections on Insurance Coverage and HIV Prevention for Older Adults

An “A” letter grade indicates that the panel recommends the service and finds there is high certainty that the service has a substantial net benefit. This recommendation will help improve access to PrEP by urging health care providers to offer PrEP to people at risk for HIV. It will also trigger statutory coverage requirements for health plans and create other opportunities for making PrEP more affordable.

Published
17 June 2019
From
O'Neill Institute

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.